Zebrafish models of major depressive disorders

Journal of Neuroscience Research

Volumn 94, Issue 1, 2016, Pages 3-14

  Fonseka, Trehani M ^a,b   Wen, Xiao Yan ^c,d   Foster, Jane A ^a,e   Kennedy, Sidney H ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Antidepressants; Behavior; Danio rerio; Depression; High throughput screen; Stress

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOLOGICAL MARKER; DOPAMINE; NORADRENALIN; PSYCHOTROPIC AGENT; SEROTONIN;

ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL FACTOR; GENETIC SCREENING; HEREDITY; HIGH THROUGHPUT SCREENING; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MITOCHONDRIAL RESPIRATION; NEUROANATOMY; NEUROCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; SOCIAL BEHAVIOR; ZEBRA FISH; ANIMAL; DISEASE MODEL; HUMAN;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; HUMANS; ZEBRAFISH;

EID: 84945470940     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23639     Document Type: Article

References (137)

1. Ahmad F, Richardson MK. 2013. Exploratory behaviour in the open field test adapted for larval zebrafish: impact of environmental complexity. Behav Processes 92:88-98.
2. Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M. 2007. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 155:245-256.
3. Airhart MJ, Lee DH, Wilson TD, Miller BE, Miller MN, Skalko RG. 2007. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (Prozac). Neurotoxicol Teratol 29:652-664.
4. Airhart MJ, Lee DH, Wilson TD, Miller BE, Miller MN, Skalko RG, Monaco PJ. 2012. Adverse effects of serotonin depletion in developing zebrafish. Neurotoxicol Teratol 34:152-160.
5. Aldeco M, Arslan BK, Edmondson DE. 2011. Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B. Comp Biochem Physiol B Biochem Mol Biol 159:78-83.
6. Alsop D, Vijayan M. 2009. The zebrafish stress axis: molecular fallout from the teleost-specific genome duplication event. Gen Comp Endocrinol 61:62-66.
7. Amo R, Aizawa H, Takahoko M, Kobayashi M, Takahashi R, Aoki T, Okamoto H. 2010. Identification of the zebrafish ventral habenula as a homolog of the mammalian lateral habenula. J Neurosci 30:1566-1574.
8. Anichtchik O, Sallinen V, Peitsaro N, Panula P. 2006. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). J Comp Neurol 498:593-610.
9. Barba-Escobedo PA, Gould GG. 2012. Visual social preferences of lone zebrafish in a novel environment: strain and anxiolytic effects. Genes Brain Behav 11:366-373.
10. Barden N. 2004. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29:185-193.
11. Becker C, Zeau B, Rivat C, Blugeot A, Hamon M, Benoliel JJ. 2008. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol Psychiatry 13:1079-1092.
12. Benato F, Colletti E, Skobo T, Moro E, Colombo L, Argenton F, Dalla Valle L. 2014. A living biosensor model to dynamically trace glucocorticoid transcriptional activity during development and adult life in zebrafish. Mol Cell Endocrinol 392:60-72.
13. Bencan Z, Sledge D, Levin ED. 2009. Buspirone, chlordiazepoxide, and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 94:75-80.
14. Bhagwagar Z, Hafizi S, Cowen PJ. 2005. Increased salivary cortisol after waking in depression. Psychopharmacology 182:54-57.
15. Bilotta J, Risner ML, Davis EC, Haggbloom SJ. 2005. Assessing appetitive choice discrimination learning in zebrafish. Zebrafish 2:259-268.
16. Blaser RE, Penalosa YM. 2011. Stimuli affecting zebrafish (Danio rerio) behavior in the light/dark preference test. Physiol Behav 104:831-837.
17. Blaser RE, Rosemberg DB. 2012. Measures of anxiety in zebrafish (Danio rerio): dissociation of black/white preference and novel tank test. PLoS One 7:e36931.
18. Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. 2008. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 33:320-331.
19. Bourin M, Hascoet M. 2003. The mouse light/dark box test. Eur J Pharmacol 463:55-65.
20. Braida D, Ponzoni L, Martucci R, Sparatore F, Gotti C, Sala M. 2014. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. Psychopharmacology 231:1975-1985.
21. Brustein E, Chong M, Holmqvist B, Drapeau P. 2003. Serotonin patterns locomotor network activity in the developing zebrafish by modulating quiescent periods. J Neurobiol 57:303-322.
22. Budziszewska B. 2002. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function. Pol J Pharmacol 54:343-349.
23. Cachat J, Canavello P, Elegante M, Bartels B, Hart P, Bergner C, Egan R, Duncan A, Tien D, Chung A, Wong K, Goodspeed J, Tan J, Grimes C, Elkhayat S, Suciu C, Rosenberg M, Chung KM, Kadri F, Roy S, Gaikwad S, Stewart A, Zapolsky I, Gilder T, Mohnot S, Beeson E, Amri H, Zukowska Z, Soignier RD, Kalueff AV. 2010. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 208:371-376.
24. Cachat J, Stewart A, Utterback E, Hart P, Gaikwad S, Wong K, Kyzar E, Wu N, Kalueff AV. 2011. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS One 6:e17597.
25. Canavello PR, Cachat JM, Beeson EC, Laffoon AL, Grimes C, Haymore WA, Elegante MF, Bartels BK, Hart PC, Elkhayat SI. 2011. Measuring endocrine (cortisol) responses of zebrafish to stress. In: Kalueff Alan V, Cachat Jonathan M, editors. Zebrafish neurobehavioral protocols. New York: Springer. p 135-142.
26. Carboni L, Piubelli C, Pozzato C, Astner H, Arban R, Righetti PG, Hamdan M, Domenici E. 2006. Proteomic analysis of rat hippocampus after repeated psychosocial stress. Neuroscience 137:1237-1246.
27. Carvalho AF, Miskowiak KK, Hyphantis TN, Kohler CA, Alves GS, Bortolato B, Sales PM, Machado-Vieira R, Berk M, McIntyre RS. 2014. Cognitive dysfunction in depression-pathophysiology and novel targets. CNS Neurol Disord Drug Targets 13:1819-1835.
28. Chakravarty S, Reddy BR, Sudhakar SR, Saxena S, Das T, Meghah V, Brahmendra Swamy CV, Kumar A, Idris MM. 2013. Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: altered brain proteome profile implicates mitochondrial dysfunction. PLoS One 8:e63302.
29. Champagne DL, Hoefnagels CC, de Kloet RE, Richardson MK. 2010. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 214:332-342.
30. Cheng RK, Jesuthasan SJ, Penney TB. 2014. Zebrafish forebrain and temporal conditioning. Philos Trans R Soc Lond B Biol Sci 369:20120462.
31. Cruwys T, Dingle GA, Haslam C, Haslam SA, Jetten J, Morton TA. 2013. Social group memberships protect against future depression, alleviate depression symptoms, and prevent depression relapse. Soc Sci Med 98:179-186.
32. Dahlbom SJ, Backstrom T, Lundstedt-Enkel K, Winberg S. 2012. Aggression and monoamines: effects of sex and social rank in zebrafish (Danio rerio). Behav Brain Res 228:333-338.
33. Dailly E, Chenu F, Renard CE, Bourin M. 2004. Dopamine, depression. and antidepressants. Fundam Clin Pharmacol 18:601-607.
34. Dal Santo G, Conterato GM, Barcellos LJ, Rosemberg DB, Piato AL. 2014. Acute restraint stress induces an imbalance in the oxidative status of the zebrafish brain. Neurosci Lett 558:103-108.
35. Danet M, Lapiz-Bluhm S, Morilak DA. 2010. A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment. Int J Neuropsychopharmacol 13:997-1009.
36. Darland T, Dowling JE. 2001. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci U S A 98:11691-11696.
37. Duman RS. 2014. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci 16:11-27.
38. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, Elkhayat SI, Bartels BK, Tien AK, Tien DH, Mohnot S, Beeson E, Glasgow E, Amri H, Zukowska Z, Kalueff AV. 2009. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 205:38-44.
39. Ellis LD, Soanes KH. 2012. A larval zebrafish model of bipolar disorder as a screening platform for neurotherapeutics. Behav Brain Res 233:450-457.
40. Engeszer RE, Barbiano LA, Ryan MJ, Parichy DM. 2007. Timing and plasticity of shoaling behaviour in the zebrafish, Danio rerio. Anim Behav 74:1269-1275.
41. Feng CW, Wen ZH, Huang SY, Hung HC, Chen CH, Yang SN, Chen NF, Wang HM, Hsiao CD, Chen WF. 2014. Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish 11:227-239.
42. Gabriel JP, Mahmood R, Kyriakatos A, Soll I, Hauptmann G, Calabrese RL, El Manira A. 2009. Serotonergic modulation of locomotion in zebrafish: endogenous release and synaptic mechanisms. J Neurosci 29:10387-10395.
43. Gaikwad S, Stewart A, Hart P, Wong K, Piet V, Cachat J, Kalueff AV. 2011. Acute stress disrupts performance of zebrafish in the cued and spatial memory tests: the utility of fish models to study stress-memory interplay. Behav Processes 87:224-230.
44. Gerlai R. 2011. Associative learning in zebrafish (Danio rerio). Methods Cell Biol 101:249-270.
45. Ghisleni G, Capiotti KM, Da Silva RS, Oses JP, Piato AL, Soares V, Bogo MR, Bonan CD. 2012. The role of CRH in behavioral responses to acute restraint stress in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 36:176-182.
46. Griffiths BB, Schoonheim PJ, Ziv L, Voelker L, Baier H, Gahtan E. 2012. A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response. Front Behav Neurosci 6:68.
47. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, McLaren S, Sealy I, Caccamo M, Churcher C, Scott C, Barrett JC, Koch R, Rauch GJ, White S, Chow W, Kilian B, Quintais LT, Guerra-Assuncao JA, Zhou Y, Gu Y, Yen J, Vogel JH, Eyre T, Redmond S, Banerjee R, Chi J, Fu B, Langley E, Maguire SF, Laird GK, Lloyd D, Kenyon E, Donaldson S, Sehra H, Almeida-King J, Loveland J, Trevanion S, Jones M, Quail M, Willey D, Hunt A, Burton J, Sims S, McLay K, Plumb B, Davis J, Clee C, Oliver K, Clark R, Riddle C, Elliot D, Threadgold G, Harden G, Ware D, Begum S, Mortimore B, Kerry G, Heath P, Phillimore B, Tracey A, Corby N, Dunn M, Johnson C, Wood J, Clark S, Pelan S, Griffiths G, Smith M, Glithero R, Howden P, Barker N, Lloyd C, Stevens C, Harley J, Holt K, Panagiotidis G, Lovell J, Beasley H, Henderson C, Gordon D, Auger K, Wright D, Collins J, Raisen C, Dyer L, Leung K, Robertson L, Ambridge K, Leongamornlert D, McGuire S, Gilderthorp R, Griffiths C, Manthravadi D, Nichol S, Barker G, Whitehead S, Kay M, Brown J, Murnane C, Gray E, Humphries M, Sycamore N, Barker D, Saunders D, Wallis J, Babbage A, Hammond S, Mashreghi-Mohammadi M, Barr L, Martin S, Wray P, Ellington A, Matthews N, Ellwood M, Woodmansey R, Clark G, Cooper J, Tromans A, Grafham D, Skuce C, Pandian R, Andrews R, Harrison E, Kimberley A, Garnett J, Fosker N, Hall R, Garner P, Kelly D, Bird C, Palmer S, Gehring I, Berger A, Dooley CM, Ersan-Urun Z, Eser C, Geiger H, Geisler M, Karotki L, Kirn A, Konantz J, Konantz M, Oberlander M, Rudolph-Geiger S, Teucke M, Lanz C, Raddatz G, Osoegawa K, Zhu B, Rapp A, Widaa S, Langford C, Yang F, Schuster SC, Carter NP, Harrow J, Ning Z, Herrero J, Searle SM, Enright A, Geisler R, Plasterk RH, Lee C, Westerfield M, de Jong PJ, Zon LI, Postlethwait JH, Nusslein-Volhard C, Hubbard TJ, Roest Crollius H, Rogers J, Stemple DL. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498-503.
48. Huang Y, Zhou W, Zhang Y. 2012. Bright lighting conditions during testing increase thigmotaxis and impair water maze performance in BALB/c mice. Behav Brain Res 226:26-31.
49. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK. 2013. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227-229.
50. Iniguez SD, Riggs LM, Nieto SJ, Dayrit G, Zamora NN, Shawhan KL, Cruz B, Warren BL. 2014. Social defeat stress induces a depression-like phenotype in adolescent male c57BL/6 mice. Stress 17:247-255.
51. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH. 2000. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5:142-149.
52. Jungke P, Ostrow G, Li JL, Norton S, Nieber K, Kelber O, Butterweck V. 2011. Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine. Psychopharmacology 213:757-772.
53. Kalueff AV, Gebhardt M, Stewart AM, Cachat JM, Brimmer M, Chawla JS, Craddock C, Kyzar EJ, Roth A, Landsman S, Gaikwad S, Robinson K, Baatrup E, Tierney K, Shamchuk A, Norton W, Miller N, Nicolson T, Braubach O, Gilman CP, Pittman J, Rosemberg DB, Gerlai R, Echevarria D, Lamb E, Neuhauss SC, Weng W, Bally-Cuif L, Schneider H, Zebrafish Neuroscience Research Consortium. 2013. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10:70-86.
54. Kalueff AV, Echevarria DJ, Stewart AM. 2014a. Gaining translational momentum: more zebrafish models for neuroscience research. Prog Neuropsychopharmacol Biol Psychiatry 55:1-6.
55. Kalueff AV, Stewart AM, Gerlai R. 2014b. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 35:63-75.
56. Karnik I, Gerlai R. 2012. Can zebrafish learn spatial tasks? An empirical analysis of place and single CS-US associative learning. Behav Brain Res 233:415-421.
57. Kedracka-Krok S, Fic E, Jankowska U, Jaciuk M, Gruca P, Papp M, Kusmider M, Solich J, Debski J, Dadlez M, Dziedzicka-Wasylewska M. 2010. Effect of chronic mild stress and imipramine on the proteome of the rat dentate gyrus. J Neurochem 113:848-859.
58. Khor BS, Jamil MF, Adenan MI, Shu-Chien AC. 2011. Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS One 6:e28340.
59. Khor YM, Soga T, Parhar IS. 2013. Caffeine neuroprotects against dexamethasone-induced anxiety-like behaviour in the zebrafish (Danio rerio). Gen Comp Endocrinol 181:310-315.
60. Kivimaki M, Virtanen M, Vartia M, Elovainio M, Vahtera J, Keltikangas-Jarvinen L. 2003. Workplace bullying and the risk of cardiovascular disease and depression. Occup Environ Med 60:779-783.
61. Kokaia Z, Gido G, Ringstedt T, Bengzon J, Kokaia M, Siesjo BK, Persson H, Lindvall O. 1993. Rapid increase of BDNF mRNA levels in cortical neurons following spreading depression: regulation by glutamatergic mechanisms independent of seizure activity. Brain Res Mol Brain Res 19:277-286.
62. Krug RG 2nd, Poshusta TL, Skuster KJ, Berg MR, Gardner SL, Clark KJ. 2014. A transgenic zebrafish model for monitoring glucocorticoid receptor activity. Genes Brain Behav 13:478-487.
63. Kyzar E, Stewart AM, Landsman S, Collins C, Gebhardt M, Robinson K, Kalueff AV. 2013. Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish. Brain Res 1527:108-116.
64. Laifenfeld D, Karry R, Klein E, Ben-Shachar D. 2005. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study. Biol Psychiatry 57:716-725.
65. Levin ED. 2011. Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development. Rev Neurosci 22:75-84.
66. Levin ED, Bencan Z, Cerutti DT. 2007. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 90:54-58.
67. Lopez-Patino MA, Yu L, Cabral H, Zhdanova IV. 2008. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 93:160-171.
68. Maaswinkel H, Le X, He L, Zhu L, Weng W. 2013. Dissociating the effects of habituation, black walls, buspirone, and ethanol on anxiety-like behavioral responses in shoaling zebrafish. A 3D approach to social behavior. Pharmacol Biochem Behav 108:16-27.
69. MacMillan HL, Fleming JE, Streiner DL, Lin E, Boyle MH, Jamieson E, Duku EK, Walsh CA, Wong MY, Beardslee WR. 2001. Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry 158:1878-1883.
70. Mann KD, Hoyt C, Feldman S, Blunt L, Raymond A, Page-McCaw PS. 2010. Cardiac response to startle stimuli in larval zebrafish: sympathetic and parasympathetic components. Am J Physiol Regul Integr Comp Physiol 298:R1288-R1297.
71. Marchand WR, Lee JN, Suchy Y, Johnson S, Thatcher J, Gale P. 2012. Aberrant functional connectivity of corticobasal ganglia circuits in major depression. Neurosci Lett 514:86-90.
72. Mathur P, Guo S. 2011. Differences of acute versus chronic ethanol exposure on anxiety-like behavioral responses in zebrafish. Behav Brain Res 219:234-239.
73. Maximino C, Herculano AM. 2010. A review of monoaminergic neuropsychopharmacology in zebrafish. Zebrafish 7:359-378.
74. Maximino C, de Brito TM, de Mattos Dias CAG, Gouveia A, Morato S. 2010. Scototaxis as anxiety-like behavior in fish. Nat Protoc 5:209-216.
75. Maximino C, Araujo J, Leao LK, Grisolia AB, Oliveira KR, Lima MG, Batista Ede J, Crespo-Lopez ME, Gouveia A Jr, Herculano AM. 2011a. Possible role of serotoninergic system in the neurobehavioral impairment induced by acute methylmercury exposure in zebrafish (Danio rerio). Neurotoxicol Teratol 33:727-734.
76. Maximino C, da Silva AW, Gouveia A Jr, Herculano AM. 2011b. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog Neuropsychopharmacol Biol Psychiatry 35:624-631.
77. Maximino C, Puty B, Benzecry R, Araujo J, Lima MG, de Jesus Oliveira Batista E, Renata de Matos Oliveira K, Crespo-Lopez ME, Herculano AM. 2013a. Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine, and parachlorophenylalanine (pCPA) in two behavioral models. Neuropharmacology 71:83-97.
78. Maximino C, Puty B, Matos Oliveira KR, Herculano AM. 2013b. Behavioral and neurochemical changes in the zebrafish leopard strain. Genes Brain Behav 12:576-582.
79. Mazure CM. 1998. Life stressors as risk factors in depression. Clin Psychol Sci Pract 5:291-313.
80. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H. 2004. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptor subunits in frontal cortical brain region. J Neurosci 24:1478-1485.
81. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S. 2006. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63:1209-1216.
82. Meyer JH, Wilson AA, Sagrati S, Miler L, Rusjan P, Bloomfield PM, Clark M, Sacher J, Voineskos AN, Houle S. 2009. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch Gen Psychiatry 66:1304-1312.
83. Miscevic F, Rotstein O, Wen XY. 2012. Advances in zebrafish high content and high throughput technologies. Comb Chem High Throughput Screen 15:515-521.
84. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
85. Mueller KP, Neuhauss SC. 2010. Behavioral neurobiology: how larval fish orient towards the light. Curr Biol 20:R159-R161.
86. Nguyen M, Stewart AM, Kalueff AV. 2014. Aquatic blues: modeling depression and antidepressant action in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 55:26-39.
87. Nikisch G. 2009. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuro Endocrinol Lett 30:11-16.
88. Nissen S, Liang S, Shehktman T, Kelsoe JR, Bipolar Genome Study (BiGS), Greenwood TA, Nievergelt CM, McKinney R, Shilling PD, Smith EN, Schork NJ, Bloss CS, Nurnberger JI Jr, Edenberg HJ, Foroud T, Koller DL, Gershon ES, Liu C, Badner JA, Scheftner WA, Lawson WB, Nwulia EA, Hipolito M, Coryell W, Rice J, Byerley W, McMahon FJ, Berrettini WH, Potash JB, Zandi PP, Mahon PB, McInnis MG, Zollner S, Zhang P, Craig DW, Szelinger S, Barrett TB, Schulze TG. 2012. Evidence for association of bipolar disorder to haplotypes in the 22q12.3 region near the genes stargazin, IFT27, and parvalbumin. Am J Med Genet B Neuropsychiatr Genet 159B:941-B950.
89. Norton WH. 2012. Measuring larval zebrafish behavior: locomotion, thigmotaxis, and startle. In: Kalueff Alan V, Cachat Jonathan M, editors. Zebrafish neurobehavioral protocols. New York: Springer. p 3-20.
90. Oliveira TA, Koakoski G, da Motta AC, Piato AL, Barreto RE, Volpato GL, Barcellos LJ. 2014. Death-associated odors induce stress in zebrafish. Horm Behav 65:340-344.
91. Pagnussat N, Piato AL, Schaefer IC, Blank M, Tamborski AR, Guerim LD, Bonan CD, Vianna MR, Lara DR. 2013. One for all and all for one: the importance of shoaling on behavioral and stress responses in zebrafish. Zebrafish 10:338-342.
92. Panula P, Sallinen V, Sundvik M, Kolehmainen J, Torkko V, Tiittula A, Moshnyakov M, Podlasz P. 2006. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 3:235-247.
93. Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, Sundvik M, Sallinen V. 2010. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 40:46-57.
94. Pariante CM. 2004. Glucocorticoid receptor function in vitro in patients with major depression. Stress 7:209-219.
95. Pariante CM, Lightman SL. 2008. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464-468.
96. Parra KV, Adrian JC Jr, Gerlai R. 2009. The synthetic substance hypoxanthine 3-N-oxide elicits alarm reactions in zebrafish (Danio rerio). Behav Brain Res 205:336-341.
97. Paull GC, Filby AL, Giddins HG, Coe TS, Hamilton PB, Tyler CR. 2010. Dominance hierarchies in zebrafish (Danio rerio) and their relationship with reproductive success. Zebrafish 7:109-117.
98. Pavlidis M, Sundvik M, Chen YC, Panula P. 2011. Adaptive changes in zebrafish brain in dominant-subordinate behavioral context. Behav Brain Res 225:529-537.
99. Piato AL, Capiotti KM, Tamborski AR, Oses JP, Barcellos LJ, Bogo MR, Lara DR, Vianna MR, Bonan CD. 2011. Unpredictable chronic stress model in zebrafish (Danio rerio): behavioral and physiological responses. Prog Neuropsychopharmacol Biol Psychiatry 35:561-567.
100. Pittman JT, Lott CS. 2014. Startle response memory and hippocampal changes in adult zebrafish pharmacologically induced to exhibit anxiety/depression-like behaviors. Physiol Behav 123:174-179.
101. Pytliak M, Vargova V, Mechírová V, Felsoci M. 2011. Serotonin receptors-from molecular biology to clinical applications. Physiol Res 60:15-25.
102. Ressler KJ, Nemeroff CB. 2000. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12:2-19.
103. Reyhanian N, Volkova K, Hallgren S, Bollner T, Olsson PE, Olsen H, Hallstrom IP. 2011. 17Alpha-ethinyl estradiol affects anxiety and shoaling behavior in adult male zebrafish (Danio rerio). Aquat Toxicol 105:41-48.
104. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. 2009. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34:1021-1029.
105. Richendrfer H, Pelkowski SD, Colwill RM, Creton R. 2012. On the edge: pharmacological evidence for anxiety-related behavior in zebrafish larvae. Behav Brain Res 228:99-106.
106. Riehl R, Kyzar E, Allain A, Green J, Hook M, Monnig L, Rhymes K, Roth A, Pham M, Razavi R, Dileo J, Gaikwad S, Hart P, Kalueff AV. 2011. Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicol Teratol 33:658-667.
107. Rock PL, Roiser JP, Riedel WJ, Blackwell AD. 2014. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 44:2029-2040.
108. Roiser JP, Sahakian BJ. 2013. Hot and cold cognition in depression. CNS Spectr 18:139-149.
109. Ruuskanen JO, Peitsaro N, Kaslin JV, Panula P, Scheinin M. 2005. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA, and receptor distributions. J Neurochem 94:1559-1569.
110. Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, Stewart DE, Meyer JH. 2010. Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry 67:468-474.
111. Sackerman J, Donegan JJ, Cunningham CS, Nguyen NN, Lawless K, Long A, Benno RH, Gould GG. 2010. Zebrafish behavior in novel environments: effects of acute exposure to anxiolytic compounds and choice of Danio rerio line. Int J Comp Psychol 23:43-61.
112. Sallinen V, Sundvik M, Reenila I, Peitsaro N, Khrustalyov D, Anichtchik O, Toleikyte G, Kaslin J, Panula P. 2009. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 109:403-415.
113. Sartorius A, Henn FA. 2007. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med Hypoth 69:1305-1308.
114. Schnorr SJ, Steenbergen PJ, Richardson MK, Champagne DL. 2012. Measuring thigmotaxis in larval zebrafish. Behav Brain Res 228:367-374.
115. Shih JC. 1991. Molecular basis of human MAO A and B. Neuropsychopharmacology 4:1-7.
116. Shulman KI, Herrmann N, Walker SE. 2013. Current place of monoamine oxidase inhibitors in the treatment of depression. CNS Drugs 27:789-797.
117. Sison M, Gerlai R. 2010. Associative learning in zebrafish (Danio rerio) in the plus maze. Behav Brain Res 207:99-104.
118. Small KM, McGraw DW, Liggett SB. 2003. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43:381-411.
119. Spence R, Gerlach G, Lawrence C, Smith C. 2008. The behaviour and ecology of the zebrafish, Danio rerio. Biol Rev Camb Philos Soc 83:13-34.
120. Steenbergen PJ, Richardson MK, Champagne DL. 2011. The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry 35:1432-1451.
121. Stewart A, Kadri F, DiLeo J, Min Chung K, Cachat J, Goodspeed J, Suciu C, Roy S, Gaikwad S, Wong K. 2010. The developing utility of zebrafish in modeling neurobehavioral disorders. Int J Comp Psychol 23: 104-120.
122. Stewart A, Maximino C, de Brito TM, Herculano AM, Gouveia Jr. A, Morato S, Cachat JM, Gaikwad S, Elegante MF, Hart PC. 2011. Neurophenotyping of adult zebrafish using the light/dark box paradigm. In: Kalueff Alan V, Cachat Jonathan M, editors. Zebrafish neurobehavioral protocols. New York: Springer. p 157-167.
123. Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff AV. 2012. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 62:135-143.
124. Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff AV. 2014. Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci 37:264-278.
125. Stratmann M, Konrad C, Kugel H, Krug A, Schoning S, Ohrmann P, Uhlmann C, Postert C, Suslow T, Heindel W, Arolt V, Kircher T, Dannlowski U. 2014. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One 9:e102692.
126. Swain HA, Sigstad C, Scalzo FM. 2004. Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). Neurotoxicol Teratol 26:725-729.
127. Teles MC, Dahlbom SJ, Winberg S, Oliveira RF. 2013. Social modulation of brain monoamine levels in zebrafish. Behav Brain Res 253:17-24.
128. Tobe EH. 2013. Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr Dis Treat 9:567-573.
129. Tudorache C, Schaaf MJ, Slabbekoorn H. 2013. Covariation between behaviour and physiology indicators of coping style in zebrafish (Danio rerio). J Endocrinol 219:251-258.
130. Tudorache C, Ter Braake A, Tromp M, Slabbekoorn H, Schaaf MJ. 2015. Behavioral and physiological indicators of stress coping styles in larval zebrafish. Stress 18:121-128.
131. Wang Y, Takai R, Yoshioka H, Shirabe K. 2006. Characterization and expression of serotonin transporter genes in zebrafish. Tohoku J Exp Med 208:267-274.
132. Wang Z, Nishimura Y, Shimada Y, Umemoto N, Hirano M, Zang L, Oka T, Sakamoto C, Kuroyanagi J, Tanaka T. 2009. Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation. Gene 446:18-27.
133. Weger BD, Weger M, Nusser M, Brenner-Weiss G, Dickmeis T. 2012. A chemical screening system for glucocorticoid stress hormone signaling in an intact vertebrate. ACS Chem Biol 7:1178-1183.
134. Wong K, Elegante M, Bartels B, Elkhayat S, Tien D, Roy S, Goodspeed J, Suciu C, Tan J, Grimes C, Chung A, Rosenberg M, Gaikwad S, Denmark A, Jackson A, Kadri F, Chung KM, Stewart A, Gilder T, Beeson E, Zapolsky I, Wu N, Cachat J, Kalueff AV. 2010. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 208:450-457.
135. Wong RY, Oxendine SE, Godwin J. 2013. Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment. BMC Genomics 14:348.
136. Yu JJ, Zhang Y, Wang Y, Wen ZY, Liu XH, Qin J, Yang JL. 2013. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology 225:361-372.
137. Ziv L, Muto A, Schoonheim PJ, Meijsing SH, Strasser D, Ingraham HA, Schaaf MJ, Yamamoto KR, Baier H. 2013. An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol Psychiatry 18:681-691.